Peer Review History
| Original SubmissionAugust 11, 2021 |
|---|
|
PONE-D-21-23433Identifying putative ventilation-perfusion distributions in COVID-19 pneumoniaPLOS ONE Dear Dr. Robbins, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Adélia Sequeira, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. Additional Editor Comments The manuscript deals with a very interesting topic and a new mathematical model. Based on the advice received from our reviewers, I feel that your manuscript could be reconsidered for publication should you be prepared to incorporate major revisions. When preparing your revised manuscript, you are asked to carefully consider the reviewers comments, which can be found below, and submit a list of responses to the comments. One particular issue needs your special attention: a complete rewriting of the abstract and introduction is required in order to understand the main purpose of the paper. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: N/A Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This paper deals with the identification of ventilation-perfusion imbalances in COVID-19 pneumonia. The topic is interesting. However, the paper presents major drawbacks for which the paper cannot be accepted in the present form: it requires a full rewriting before being reconsidered. 1) One should read well down into the paper, close to the end, to understand the purpose of the paper and its goals. Basically, the paper proposes a modification of a mathematical model that is to be personalized to patients. A complete rewriting of the abstract and introduction is required. 2) Several unclear and misleading terms are used. Accuracy and existence of solutions must be properly accompanied with mathematical and numerical models, other than recast in the proper context. The identification of solutions is unclear too. 3) Model personalization and validation are not mentioned; if so, they are presented in the paper in a narrative manner that prevents comprehension of the procedures used. 4) The mathematical model is not clearly presented. The authors discuss how they arrived to the model, but then the set of equations to be solved (compartmental 0D models) are not clearly written. How are these differing from other models in literature? How is the model validated? 5) The issue of mass conservation is introduced in the abstract, but then the discussion at the end of the paper fail to highlight the reason for which this is unlikely to hold. In addition, one may find hard to believe that a physical principle in classic mechanics like mass conservation does not hold in this context. 6) The motivation to this work appears to come from drawbacks from a paper in literature by Busana et al., which is unpleased by the authors. I believe that, regardless of the pros and cons of the mentioned previous study, negative views of this work should be recast in a more constructive manner. Specific comments for the abstract. 7) Abstract, 21 (and Introduction). Rephrase the first part of the abstract. Motivations to this paper and its content should not move from negative views on previously appeared papers. “For no patient they did obtain accurate results”. Rather, try recasting the previous work in a positive manner. 8) Abstract, 27. After accuracy of previous results is discussed, the goal of the paper is stated “to determine whether such solutions exist, and if so, to develop accurate method by which possible solutions can be identified”. What is the the analysis of solutions’ existence that is established in this paper? What does solution identification mean? 9) Abstract, 30. What does it mean that “no solution was possible”? 10) Abstract, 32. What does it mean “precise solution to the problem”? 11) Abstract, 34. In which sense are solutions “exact”? 12) Abstract, 34-35. The statement is unclear. What is the purpose of the method that is failing? Performing numerical discretization of the mathematical model? Or performing data assimilation? 13) Abstract, 36. What is the conclusions and the proposed remedy to the unlikely assumption made on mass conservation? Reviewer #2: The paper deals with a new mathematical model to determine a ventilation-perfusion distribution able to reproduce the oxygen and Co2 partial pressure in COVID-19 patients. The authors start from a previous model and improve it, showing with their results applied to a cohort of 5 patients the improvements with respect to the previous results. The topic of the paper is of great interest due to an attempt to better understand COVID-19 effects on ventilation and perfusion of lungs in a quantitative way. However, some remarks are due and the authors should carefully fix the following points MAJOR REMARKS: 1. The authors refer to the work of Busana et al in terms too competitive, providing definite statements on such a work, e.g. “… they subsequently failed to find any accurate solutions for potential …” “… result from the hypothesis of Busana et al. are unlikely to represent the true state of gas exchange in these severely ill COVID-19 patients.” The authors should clearly state that their model is an extension of that of Busana et al, with an improvement in some sense of the results, acknowledging the fact that the Busana model is the starting point. 2. Related to the previous point, the authors used too much strong statements about their results, e.g.: “… we have demonstrated that no such distributions exist for their first …” “… we have demonstrated that multiple, indeed infinite sets, of potential V̇/Q̇ distributions exist…” It seems to me that the results of this paper are more reasonable than the ones found in Busana et al, but that there is no any validation, so I would avoid to use “demonstrate”. 3. Related to the previous point: The authors used the available data for the parameter calibration, but not for the validation, is this true? If yes, this should be clearly stated in the text 4. Also the number of cases (5) is not enough to demonstrate anything. It is noticeable to have some data after 1 year from pandemic, but the authors should again change the tone of their sentences, without any definite answer. Their results in fact “seem to show that …. “ Moreover, if I well understood, the data were obtained by Busana et al and this is another reason why the authors should refer to this paper in different terms (see point 1) 4. Methods – Overview: The journal is read by scientists with different expertise, thus I suggest to better contextualize the physical processes and the method. For example: What are the compartments? What is the pure shunt and pure deadspace? Not all the readers are familiar with this. 5. Eqns (1) and (2): I am not sure that the authors explicitly give the expression of g. In any case, Eqn (2) is useless, is the same of (1) 6. Methods: the authors should summarize all the procedure with a final algorithm or better with a flowchart, highlighting: - the input - how could they be obtained (measures, assumptions, …) - the output - their clinical relevance 7. Figures 1 and 2: It seems to me that different behaviours are experienced by Patients 2,3 vs 4,5. Please comment on this 8. Details on the numerical methods used to find solutions should be provided 9. The clinical relevance of the results should be discussed 10. Limitations and future perspective should be added MINOR REMARKS: 1. Line 294 should be after the caption Reviewer #3: n.a (this is not a review of the manuscript) n.a (this is not a review of the manuscript) n.a (this is not a review of the manuscript) n.a (this is not a review of the manuscript) n.a (this is not a review of the manuscript) ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-23433R1Identifying putative ventilation-perfusion distributions in COVID-19 pneumoniaPLOS ONE Dear Dr. Robbins, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 27 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, António M. Lopes, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper improved after a significant revision that partially incorporated the major and minor questions. I think the paper has merit, even if some major points persist and must be thoroughly addressed. I am very confused by the use of the words “solution”, “model”, and “problem”. Mathematically speaking, a solution is a value, number, function, etc… that fulfill the conditions set by equations. Here, I find very hard to understand which are the equations to be solved (models and problems) and which variables are the solutions by reading through the text. Figure 1 is adding confusion rather than giving a clear picture of the problems/equations and solutions searched for. What is meaning that a “solution is not possible”? I also find very difficult to identify data and solutions (?) in the models. The concept of “distribution” should be introduced and carefully presented. If I understand correctly, this work revolves around the idea of calculating such distribution instead of a sort of “trial and error” approach by Busana et al., who explore the space of plausible parameters to identify a plausible combination of these ones. Can this distribution interpreted instead as a combination of values? 118: “conservation of matter”. Shouldn’t be conservation of mass instead? Here, we are not working in the framework of relativistic mechanics, but of classical mechanics. 150: Eq. (5). g is not defined, if not much later in the text. Similarly for other mathematical notation. Equations are numbered in round brackets (XY). However, in the text they are referred to as Eq XY. Instead, bibliographic references are cited in round brackets (in place of more common squared brackets), which is adding confusion to the “Method” section. 356-365: are these part of the table caption? Reviewer #2: It is hard to evaluate the changes made by the authors. They should clearly indicate in their answers the number of pages and lines where changes have been made and, possibly, indicate in colours such changes in the text ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-21-23433R2 Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia PLOS ONE Dear Dr. Robbins, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. You may see that reviewer 2 is still unclear regarding the changes made to the mansucript as a result of their comments provided in the decision letter dated November 4th 2021. We appreciate that while in the rebuttal letter following the first round of review, you have provided a response to every comment made by this reviewer, however it is not clear the changes made to the mansucript text as a result of their feedback.During this round of revision, we suggest explicitly referring to what as changed in the revised version of the mansucript when compared to the original submitted mansucript (using line numbers if possible) to support your responses to the reviewers 2 comments. This will help the reviewers and Academic Editor in re-evaluating your mansucript. Please submit your revised manuscript by Jun 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Lucinda Shen Staff Editor on behalf of António M. Lopes, PhD Academic Editor PLOS ONE Additional Editor Comments: The authors should pay attention to the comments of reviewer #2. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Response to comment 1 Thank you – this is very helpful comment to guide further revision. We have added a paragraph at the beginning of the Methods to define the terms ‘solution’, ‘model’ and ‘problem’. A solution is a set of paired values for ventilation and perfusion {Vi, Qi}, that will result in calculated values for arterial PCO2 and PO2 that, to within experimental error, match the measured values from the patient. We illustrate solutions in the figures. The meaning of a ‘solution is not possible’ is that, after applying constraints relating to the patient, there are Response to Reviewers no sets {Vi, ,Qi} that form a solution to the problem. This can arise if one or more of the constraints is wrong. >>> This must be made very clear from the beginning, that is from the abstract. Response to comment 2 We have added a definition of distribution in the paragraph at the start of the Methods. Busana et al do not state what their parameters are, but basically their parameters are used to generate the ‘ V/Q distribution’, which is the set of paired values {Vi, Qi}. The number of paired values in this set can be varied. We explore the three-compartment model of the lung – which has three pairs of values in this set (and has a very important place in the development of theory around gas exchange in the lung), a four-compartment model of the lung, and a ‘multi’-compartment model of the lungs, where the number of Vi, Qi pairs is very much higher and where it is really being used as a computational approximation to a continuous distribution (where the pairs of values Vi, Qi in the set {Vi, Qi} would be infinite). So the answer to your question is yes. The distribution is the set {Vi, Qi}. >>> Also this must be very clear from the beginning of the paper. >>> I recommend to further ease negative views on the paper of Busana et al. (like “failed to find any solution”, abstract line 29) Reviewer #2: I cannot find the answers to my remarks. IN previous submission, the changes in the text were missing, now the answers are missing. It is difficult to evaluate the improvement of the paper ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia PONE-D-21-23433R3 Dear Dr. Robbins, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, António M. Lopes, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors answered to all my issues.I suggest the paper for publication on the journal. Best regards ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-21-23433R3 Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia Dear Dr. Robbins: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. António M. Lopes Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .